<var id="thfl3"></var>
<var id="thfl3"></var>
<var id="thfl3"><video id="thfl3"><thead id="thfl3"></thead></video></var><menuitem id="thfl3"></menuitem>
<var id="thfl3"></var><cite id="thfl3"></cite><var id="thfl3"><video id="thfl3"></video></var>
<var id="thfl3"><span id="thfl3"></span></var><cite id="thfl3"><span id="thfl3"><var id="thfl3"></var></span></cite>
<ins id="thfl3"><span id="thfl3"><menuitem id="thfl3"></menuitem></span></ins>
<var id="thfl3"></var>

Fees payable to the European Medicines Agency

This content applies to human and veterinary medicines.

The European Medicines Agency (EMA) charges fees for the services it provides. The rules relating to the Agency's fees are governed by the fee regulation (Council Regulation (EC) No 297/95) and its implementing rules, as well as the pharmacovigilance fee regulation (Regulation (EU) No 658/2014).

The European Commission is currently revising EMA's fees system. For more information, see European Commission:?Evaluation of EMA's?fee system.

Fees for marketing authorisations

The Agency charges fees for applications for marketing authorisation, and for variations and other changes to marketing authorisations, as well as annual fees for authorised medicines.

Examples of current basic fees

Fee typeHuman medicinesVeterinary medicines
Marketing-authorisation application (single strength, one pharmaceutical form, one presentation)From €296,500From €148,400
Extension of marketing authorisation (level I)€89,000€37,100
Type-II variation (major variation)€89,000€44,400
Scientific adviceFrom €44,400 to €89,000From €14,600 to 44,400
Annual fee (level I)€106,300€35,600
Establishment of MRLs-€73,800

Fees are adjusted every year for inflation.

Fee reductions and incentives are available for micro, small and medium-sized enterprises (SMEs), designated orphan medicines, multiple applications on usage patent grounds and other classes of application.

Full details on all fees and fee reductions are available in the explanatory note:

Fees for human pharmacovigilance

Pharmacovigilance activities conducted at EU level for human medicines are financed by fees paid by marketing-authorisation holders. For further information regarding Pharmacovigilance fees payable to the Agency, please visit the pharmacovigilance fees page.

Paying your fees

Information and guidance on invoicing, terms and conditions of payment and how to set up a customer account with the Agency can be found on our How to pay page.

Contacting the Agency about fees

For general queries on fees such as composition and types of fee, fee prices, fee codes, application numbers and procedures, submit the EMA fees query form.


Previously applicable rules


How useful was this page?

Add your rating
3 ratings
6 ratings
1 rating
1 rating
1 rating
欧美大屁股XXXX,免费1级做爰片L在线观看,在线观看国产高清免费不卡,a 成 人小说网站在线观看